Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Non-covalent BTK inhibitor pirtobrutinib shows promise as frontline therapy for CLL/SLL

Prof Jennifer Woyach - The Ohio State University, Columbus, USA
Non-covalent BTK inhibitor pirtobrutinib shows promise as frontline therapy for CLL/SLL ( Prof Jennifer Woyach - The Ohio State University, Columbus, USA )
10 Dec 2025

Linvoseltamab monotherapy in newly diagnosed multiple myeloma shows impressive frontline responses

Prof Robert Orlowski - The University of Texas MD Anderson Cancer Center, Houston, USA
Linvoseltamab monotherapy in newly diagnosed multiple myeloma shows impressive frontline responses ( Prof Robert Orlowski - The University of Texas MD Anderson Cancer Center, Houston, USA )
10 Dec 2025

Pimicotinib in TGCT demonstrates durable responses and sustained functional improvement

Prof Hans Gelderblom - Leiden University, Leiden, Nethrlands
Pimicotinib in TGCT demonstrates durable responses and sustained functional improvement ( Prof Hans Gelderblom - Leiden University, Leiden, Nethrlands )
2 Dec 2025

Latest in bladder cancer from the second half of 2025

Dr Alison Birtle, Dr Ignacio Durán, Prof Evanguelos Xylinas, Dr Giuseppe Simone and Dr Enrique Grande
Latest in bladder cancer from the second half of 2025 ( Dr Alison Birtle, Dr Ignacio Durán, Prof Evanguelos Xylinas, Dr Giuseppe Simone and Dr Enrique Grande )
25 Nov 2025

I-DXd shows strong brain metastasis responses in extensive-stage small cell lung cancer with manageable safety

Dr Pedro Rocha - Vall d'Hebron University Hospital, Barcelona, Spain
I-DXd shows strong brain metastasis responses in extensive-stage small cell lung cancer with manageable safety ( Dr Pedro Rocha - Vall d'Hebron University Hospital, Barcelona, Spain )
6 Nov 2025

Tarlatamab improves symptoms and QoL over chemo in previously treated SCLC

Dr Giannis Mountzios - Henry Dunant Hospital Center, Athens, Greece
Tarlatamab improves symptoms and QoL over chemo in previously treated SCLC ( Dr Giannis Mountzios - Henry Dunant Hospital Center, Athens, Greece )
4 Nov 2025

Tarlatamab improves survival over chemo in 2L SCLC regardless of prior immunotherapy or chemo

Dr Giannis Mountzios - Henry Dunant Hospital Center, Athens, Greece
Tarlatamab improves survival over chemo in 2L SCLC regardless of prior immunotherapy or chemo ( Dr Giannis Mountzios - Henry Dunant Hospital Center, Athens, Greece )
4 Nov 2025

Temab-A plus bevacizumab shows promising response rates in advanced colorectal cancer

Dr Michael Cecchini - Yale School of Medicine, New Haven, USA
Temab-A plus bevacizumab shows promising response rates in advanced colorectal cancer ( Dr Michael Cecchini - Yale School of Medicine, New Haven, USA )
27 Oct 2025

ESMO 2025: Latest developments in endometrial cancer

Dr Shannon Westin, Dr Brian Slomovitz, Dr Vanda Salutari and Dr Christian Marth
ESMO 2025: Latest developments in endometrial cancer ( Dr Shannon Westin, Dr Brian Slomovitz, Dr Vanda Salutari and Dr Christian Marth )
24 Oct 2025

ESMO 2025: Precision medicine in bladder cancer

Dr Enrique Grande, Prof Syed Hussain, Dr Patrizia Giannatempo, Dr Félix Guerrero-Ramos
ESMO 2025: Precision medicine in bladder cancer ( Dr Enrique Grande, Prof Syed Hussain, Dr Patrizia Giannatempo, Dr Félix Guerrero-Ramos )
23 Oct 2025

ESMO 2025: Highlights and analysis

Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada
ESMO 2025: Highlights and analysis ( Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada )
23 Oct 2025

PRAME-targeted TCR therapy shows high response rates in metastatic uveal melanoma

Dr Sapna Patel - University of Colorado Anschutz, Aurora, USA
PRAME-targeted TCR therapy shows high response rates in metastatic uveal melanoma ( Dr Sapna Patel - University of Colorado Anschutz, Aurora, USA )
23 Oct 2025